Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Study finds virus that causes mononucleosis could raise risk of multiple sclerosis

Study finds virus that causes mononucleosis could raise risk of multiple sclerosis

Scientists succeed in teaching robots to perform challenging brain technique

Scientists succeed in teaching robots to perform challenging brain technique

New tool helps researchers to identify and detect various sub-groups of Alzheimer’s disease

New tool helps researchers to identify and detect various sub-groups of Alzheimer’s disease

Soul purpose: Seniors with strong reasons to live often live stronger

Soul purpose: Seniors with strong reasons to live often live stronger

Stabilizing TREM2 could be viable therapeutic strategy to combat Alzheimer's disease

Stabilizing TREM2 could be viable therapeutic strategy to combat Alzheimer's disease

Magnetic stimulation of the prefrontal cortex improved test subjects’ evaluation of own performance

Magnetic stimulation of the prefrontal cortex improved test subjects’ evaluation of own performance

New antibodies may halt key pathological mechanisms across several neurological diseases

New antibodies may halt key pathological mechanisms across several neurological diseases

Study: People with shorter LTL have more benefits on cognition following lifestyle intervention

Study: People with shorter LTL have more benefits on cognition following lifestyle intervention

Study reveals new opportunities for treatment of Type 2 diabetes

Study reveals new opportunities for treatment of Type 2 diabetes

Undergraduates earn top prize for developing new tool to detect Alzheimer’s disease

Undergraduates earn top prize for developing new tool to detect Alzheimer’s disease

Disease diagnostic tools win top honors in DEBUT challenge

Disease diagnostic tools win top honors in DEBUT challenge

NIH funds BU ADC with $5.4 million grant to advance research on Alzheimer's disease

NIH funds BU ADC with $5.4 million grant to advance research on Alzheimer's disease

Review focuses on possible role of neuroinflammation in Alzheimer's and Parkinson's diseases

Review focuses on possible role of neuroinflammation in Alzheimer's and Parkinson's diseases

Dancing has profound effect in reversing signs of aging in the brain

Dancing has profound effect in reversing signs of aging in the brain

Study finds no link between exercise in mid-life and cognitive fitness in later years

Study finds no link between exercise in mid-life and cognitive fitness in later years

Research finds how omega-3 supplements dampen harmful inflammatory reactions

Research finds how omega-3 supplements dampen harmful inflammatory reactions

Retina scans could help identify Alzheimer’s

Retina scans could help identify Alzheimer’s

Artificial intelligence technique recognizes signatures of dementia two years before onset

Artificial intelligence technique recognizes signatures of dementia two years before onset

Noninvasive retinal imaging may detect pathological hallmarks of Alzheimer's disease

Noninvasive retinal imaging may detect pathological hallmarks of Alzheimer's disease

Despite advance directive, dementia patient denied last wish, says spouse

Despite advance directive, dementia patient denied last wish, says spouse

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.